Barclays’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Barclays’s Portfolio NPSP Stock Details NPSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-60,000	Closed	-$2.1M	–	7495
2014 Q4	$2.1M	Sell	60,000 -621,400	-91%	-$18.6M	﹤0.01%	2491
2014 Q3	$17.7M	Buy	681,400 +139,300	+26%	+$4M	0.02%	792
2014 Q2	$17.9M	Buy	542,100 +447,600	+474%	+$12.9M	0.02%	765
2014 Q1	$2.74M	Buy	94,500 +7,700	+9%	+$265K	﹤0.01%	2241
2013 Q4	$2.6M	Buy	86,800 +33,700	+63%	+$928K	﹤0.01%	2398
2013 Q3	$1.65M	Sell	53,100 -82,100	-61%	-$1.88M	﹤0.01%	2814
2013 Q2	$2.04M	Buy	+135,200	New	+$1.87M	﹤0.01%	2522

Other funds holding NPSP

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Barclays's NPSP Position: Q1 2015 in Review

Barclays sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 205,448 shares — an estimated $7.19M sold.

Barclays first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $7.19M in Q4 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

Barclays reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Barclays sold 205,448 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $7.19M.
Barclays first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
Barclays's NPS PHARMACEUTICALS INC position peaked at $7.19M in Q4 2014.
1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.